Patient satisfaction after vitamin D supplementation in cancer survivors: A prospective cohort study
Published
September 1, 2024
Paper ID
PAP-000034
Status
Published
DOI
10.65712/tmj.test000292
Advance Services
Abstract
Background: The cost of patient satisfaction to health systems is substantial. Methods: Eligible participants were cancer survivors. Results: The adjusted odds ratio was 0.57 (95% CI 0.34 to 0.91). patient satisfaction occurred in 5% of the intervention group versus 20% of controls. Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Earlier studies of vitamin D supplementation were small or single-centre. patient satisfaction remains a leading cause of avoidable harm among cancer survivors.
The cost of patient satisfaction to health systems is substantial. patient satisfaction remains a leading cause of avoidable harm among cancer survivors. Practice around vitamin D supplementation varies widely between centres.
Materials and Methods
Missing data were handled with multiple imputation.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Eligible participants were cancer survivors. We conducted a prospective cohort study across 6 centres between 2019 and 2024.
The primary outcome was patient satisfaction, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
Results
4116 participants were included (median age 69 years). The adjusted odds ratio was 0.55 (95% CI 0.48 to 0.94). patient satisfaction occurred in 21% of the intervention group versus 28% of controls. patient satisfaction occurred in 6% of the intervention group versus 31% of controls.
The adjusted odds ratio was 0.70 (95% CI 0.43 to 0.99). The adjusted odds ratio was 0.88 (95% CI 0.27 to 0.62). 4555 participants were included (median age 48 years). Effects were consistent across prespecified subgroups.
| Group | n | Events |
|---|---|---|
| Age ≥ 65 | 257 | 99 |
| Age < 65 | 503 | 68 |
| Centre B | 832 | 50 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. 4619 participants were included (median age 69 years). patient satisfaction occurred in 4% of the intervention group versus 25% of controls.
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.79 (95% CI 0.38 to 0.60). 3046 participants were included (median age 56 years).
Discussion
These findings suggest that vitamin D supplementation is associated with better patient satisfaction in cancer survivors. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment.
These findings suggest that vitamin D supplementation is associated with better patient satisfaction in cancer survivors. Implementation will depend on staffing, cost and local protocols.
Future work should test vitamin D supplementation in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Conclusions
Vitamin D supplementation merits wider use for cancer survivors to improve patient satisfaction.
References
1. Ibrahim N, Haddad B, et al. An antibiotic stewardship programme and glycaemic control. Pediatrics. 2025;220(10):786-1545.
2. Mensah K, Ibrahim D, et al. An antibiotic stewardship programme and 30-day readmission. Ann Intern Med. 2024;163(8):347-1015.
3. Larsen L, Patel C, et al. Nurse-led discharge planning and acute kidney injury. Eur Heart J. 2012;287(10):637-923.
4. Rahman V, Yilmaz B, et al. Continuous glucose monitoring and medication adherence. Crit Care Med. 2009;324(1):742-1444.
5. Costa K, Costa D, et al. Delayed cord clamping and patient satisfaction. BMJ. 2010;287(9):288-1123.
6. Dubois B, Mueller J, et al. Delayed cord clamping and glycaemic control. JAMA. 2023;304(5):344-943.
Appendices
The statistical analysis plan is in the online supplement.